盐酸曲美他嗪辅助治疗椎——基底动脉供血不足性眩晕效果观察  

Effect of Trimetazidine Hydrochloride in the Treatment of Vertigo Caused by Vertebrobasilar Insufficiency

作　　者：周红霞[1] 王兴元[1] 曹洪兵[1] 杨善进[1] 

机构地区：[1]中国人民解放军第三五九医院内科,江苏镇江212001

出　　处：《中国继续医学教育》2017年第18期156-157,共2页China Continuing Medical Education

摘　　要：目的分析盐酸曲美他嗪辅助治疗椎—基底动脉供血不足性眩晕的效果。方法选取来我院就医的椎-基底动脉供血不足性眩晕患者50例(2012年10月—2017年3月)作为本次研究的对象,随机分2组,分别给予盐酸曲美他嗪联合氟桂利嗪、氟桂利嗪治疗,对比2组患者治疗后各项指标、治疗前后眩晕评分、症状缓解时间的差异性。结果在治疗后各项指标的比较中,观察组患者与对照组患者的结果比较,P>0.05,而在眩晕评分以及症状缓解时间的比较中,观察组优于对照组,P<0.05。结论盐酸曲美他嗪辅助治疗椎-基底动脉供血不足性眩晕患者具有一定的应用价值。Objective To analyze the effect of trimetazidine hydrochloride in the treatment of vertigo caused by vertebrobasilar insufficiency. Methods Selected 50 patients with vertebrobasilar insufficiency treated in our hospital（October 2012 to March 2017） as the object of this study, randomly divided into 2 groups, and they were were treated with trimetazidine combined with flunarizine and flunarizine treatment respectively, the differences of the indexes, the vertigo score and the remission time before and after treatment were compared between the 2 groups. Results In the comparison of the indexes after treatment, the results of the observation group and the control group had statistical sighificance difference, P〉0.05, in the vertigo score and in the time of symptom relief, the observation group was better than the control group, P〈0.05. Conclusion The clinical value of trimetazidine hydrochloride in the treatment of vertigo caused by vertebrobasilar insufficiency is certain.

关 键 词：盐酸曲美他嗪 椎-基底动脉供血不足性眩晕 效果观察 

分 类 号：R255[医药卫生—中医内科学]